Coronary Arterioscleroses

Cardiovascular
0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

OrbusNeich
OrbusNeichChina - Hong Kong
1 program
EucaLimus coronary stent systemN/A1 trial
Active Trials
NCT06621524Active Not Recruiting251Est. Jan 2029

Trial Timeline

Clinical trial activity over time

2025
2026
2027
2028
2029
OrbusNeichEucaLimus coronary stent system

Clinical Trials (1)

Total enrollment: 251 patients across 1 trials

NCT06621524OrbusNeichEucaLimus coronary stent system

EucaLimus Post-Market Registry

Start: Mar 2025Est. completion: Jan 2029251 patients
N/AActive Not Recruiting

Related Jobs in Cardiovascular

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space